R. Hofheinz

P. Kienle, S. Post, R. Hofheinz, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Locally advanced rectal cancer : Current and future perioperative treatment strategies

R. Hofheinz, R. Hofheinz, R. Hofheinz, 2020 .

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

A. Kopp-Schneider, J. Sturm, A. Kopp-Schneider, 2005, Oncology Research and Treatment.

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

M. Ychou, C. V. D. van de Velde, P. Kienle, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).

A. Hinke, R. Hofheinz, S. Al-Batran, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

T. Zhan, E. Goekkurt, J. Riera-Knorrenschild, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study

David M. Hyman, Vivek Subbiah, Jordi Rodon, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments

R. Hofheinz, Sylvie Lorenzen, Magdalena K. Scheck, 2024, Cancers.

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

T. Ettrich, G. Siegler, N. Homann, 2023, Frontiers in oncology.

Contents of Next Issues · Themenvorschau

J. Drevs, D. Strumberg, U. Massing, 2002, Oncology Research and Treatment.

Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.

S. Post, F. Wenz, R. Hofheinz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

R. Hofheinz, S. Lorenzen, M. Kripp, 2015, Journal of thoracic disease.

Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.

T. Zhan, J. Betge, M. Maenz, 2024, Journal of geriatric oncology.

Lokal fortgeschrittenes Rektumkarzinom: perioperative Therapie heute und morgen

R. Hofheinz, R. Hofheinz, R. Hofheinz, 2020, Der Onkologe.

Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group

D. Gencer, R. Hofheinz, G. M. Haag, 2024, Oncology Research and Treatment.

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

C. Bokemeyer, R. Hofheinz, K. Oechsle, 2004, British Journal of Cancer.